Data updated: Mar 10, 2026
CARISOPRODOL
CARISOPRODOL
Approved 1979-06-12
21
Indications
--
Phase 3 Trials
46
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1979-06-12
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
PIONEER PHARMS Novartis Hikma WATSON LABS ACCELRX LABS Sun Pharma SCIEGEN PHARMS HERITAGE ABLE INGENUS PHARMS LLC CHARTWELL RX Aurobindo Pharma STRIDES PHARMA EPIC PHARMA LLC POINTVIEW HLDINGS ORIENT PHARMA CO LTD SENORES PHARMS WATSON LABS TEVA NATCO MPP PHARMA OXFORD PHARMS
Active Ingredient: CARISOPRODOL
Website: ↗
CARISOPRODOL Approval History
Loading approval history...
What CARISOPRODOL Treats
21 FDA approvalsOriginally approved for its first indication in 1979 . Covers 21 distinct patient populations.
- Other (21)
Other
(21 approvals)- • Approved indication (Jun 1979)
- • Approved indication (Apr 1982)
- • Approved indication (Apr 1989)
- • Approved indication (Oct 1991)
- • Approved indication (Jan 1996)
- • Approved indication (Dec 1996)
- • Approved indication (Mar 1997)
- • Approved indication (Sep 1997)
- • Approved indication (Sep 2000)Letter
- • Approved indication (Jun 2001)Letter
- • Approved indication (Jun 2005)
- • Approved indication (Feb 2007)
- • Approved indication (Oct 2008)
- • Approved indication (Aug 2009)
- • Approved indication (Jan 2014)
- • Approved indication (Oct 2014)
- • Approved indication (Oct 2014)
- • Approved indication (Jul 2015)
- • Approved indication (Nov 2015)
- • Approved indication (May 2017)
- • Approved indication (Oct 2021)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CARISOPRODOL FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.